{"context":{"query":">>hgnc>>msigdb","source_dataset":"hgnc","target_dataset":"msigdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]HGNC:17635,10,HGNC:17635,41,0]["},"schema":"id|standard_name|collection|description|gene_count","mappings":[{"input":"HGNC:17635","source":"HGNC:17635|CD274 molecule","targets":["M10017|GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN|C7|Genes down-regulated in tumor associated macrophages conditioned by: glioblastoma versus colorectal adenocarcinoma.|194","M10107|GOBP_REGULATION_OF_CELL_ACTIVATION|C5:GO|Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand. [GOC:ai]|663","M10218|GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION|C5:GO|Any process that modulates the frequency, rate or extent of leukocyte proliferation. [GOC:add, GOC:mah]|284","M10232|GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS|C5:GO|Any process that activates or increases the frequency, rate or extent of lymphocyte death by apoptotic process. [GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|20","M10422|GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of an adaptive immune response. [GOC:add]|69","M10453|GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|Any process that modulates the frequency, rate or extent of alpha-beta T cell activation. [GOC:ai]|124","M1058|REACTOME_ADAPTIVE_IMMUNE_SYSTEM|C2:CP|Adaptive Immune System|824","M10581|GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS|C5:GO|Any process that activates or increases the frequency, rate or extent of leukocyte apoptotic process. [GOC:BHF, GOC:mtg_apoptosis]|33","M10640|GOBP_RESPONSE_TO_PEPTIDE|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus. [GOC:pr, GOC:TermGenie]|1010","M10649|GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS|C5:GO|Any process that modulates the frequency, rate or extent of leukocyte apoptotic process. [GOC:BHF, GOC:mtg_apoptosis]|98","M10653|GOBP_CELLULAR_RESPONSE_TO_LIPID|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus. [GOC:mah]|652","M10715|GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation. [GOC:add, GOC:mah]|105","M10757|GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE|C5:GO|Any process that modulates the frequency, rate, or extent of an adaptive immune response. [GOC:add]|222","M10812|GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism. [GOC:mah]|277","M10874|GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte mediated immunity. [GOC:add]|76","M1103|GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP|C2|Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].|1156","M11050|GOBP_LYMPHOCYTE_COSTIMULATION|C5:GO|The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the B- or T cell receptor to augment B- or T cell activation. [ISBN:0781735149]|50","M11182|GOCC_CELL_SURFACE|C5:GO|The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]|916","M11217|GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS|C5:GO|Any process that modulates the occurrence or rate of lymphocyte death by apoptotic process. [GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|64","M11239|GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION|C5:GO|Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell. [GOC:isa_complete]|215","M11373|GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION|C5:GO|Any process that activates or increases the frequency, rate or extent of production of a cytokine. [GOC:add, ISBN:0781735149]|519","M11609|GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND|C5:GO|Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus. [GOC:pr, GOC:TermGenie]|1257","M11678|GOBP_LEUKOCYTE_MEDIATED_IMMUNITY|C5:GO|Any process involved in the carrying out of an immune response by a leukocyte. [GO_REF:0000022, GOC:add, ISBN:0781735149]|479","M11923|GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION|C5:GO|Any process that activates or increases the frequency, rate or extent of cell adhesion. [GOC:go_curators]|506","M11973|GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION|C5:GO|Any process that activates or increases the frequency, rate or extent of leukocyte proliferation. [GOC:add, GOC:mah]|173","M11996|GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY|C5:GO|The series of molecular signals initiated by a ligand binding to a toll-like receptor of a target cell. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response. [GO_REF:0000022, GOC:add, ISBN:0781735149, PMID:12467241, PMID:12524386, PMID:12855817, PMID:15585605, PMID:15728447]|84","M12015|GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of a response to biotic stimulus. [GOC:add]|135","M12029|BILD_HRAS_ONCOGENIC_SIGNATURE|C2|Genes selected in supervised analyses to discriminate cells expressing activated HRAS [GeneID=3265] oncogene from control cells expressing GFP.|252","M12087|GOBP_CELL_CELL_ADHESION|C5:GO|The attachment of one cell to another cell via adhesion molecules. [GOC:dos]|999","M12127|GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS|C5:GO|Any process that activates, maintains or increases the rate of a response to an external stimulus. [GOC:mah]|686","M12336|GOBP_REGULATION_OF_IMMUNE_RESPONSE|C5:GO|Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. [GOC:ai]|1043","M1241|GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of an organismal process, the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs. [GOC:ai]|1284","M12491|GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|The change in morphology and behavior of a CD4-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. [CL:0000624, GOC:BHF]|135","M12514|GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM|C5:GO|Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism. [GOC:dos]|1347","M12516|GOBP_LEUKOCYTE_PROLIFERATION|C5:GO|The expansion of a leukocyte population by cell division. [GOC:add]|356","M12536|GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS|C5:GO|Any process that modulates the occurrence or rate of T cell death by apoptotic process. [GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|43","M12663|GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY|C5:GO|Any process involved in the carrying out of an immune response by a lymphocyte. [GO_REF:0000022, GOC:add, ISBN:0781735149]|377","M12740|GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. [GOC:add, GOC:mah, PMID:15546383]|44","M12756|GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production. [GOC:mah]|25","M13156|GOBP_CYTOKINE_PRODUCTION|C5:GO|The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. [GOC:add, ISBN:0781735149]|909","M13345|GOBP_REGULATION_OF_RESPONSE_TO_STRESS|C5:GO|Any process that modulates the frequency, rate or extent of a response to stress. Response to stress is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation). [GOC:dhl]|1510","M13385|GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION|C5:GO|Any process that activates or increases the frequency, rate or extent of activation. [GOC:ai]|400","M13558|GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus. [GOC:pr, GOC:TermGenie]|1726","M13637|GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY|C5:GO|Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity. [GOC:add]|202","M13744|GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell activation. [GOC:obol]|86","M13847|GOBP_ADAPTIVE_IMMUNE_RESPONSE|C5:GO|An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). [GO_REF:0000022, GOC:add, ISBN:0781735149]|765","M13966|GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION|C5:GO|Any process that stops, prevents or reduces the rate or extent of T cell proliferation. [GOC:jl]|79","M13996|GOBP_LEUKOCYTE_APOPTOTIC_PROCESS|C5:GO|Any apoptotic process in a leukocyte, an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue. [CL:0000738, GOC:BHF, GOC:mah, GOC:mtg_apoptosis]|126","M14037|GOBP_RESPONSE_TO_LIPID|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus. [GOC:sl]|955","M14275|FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN|C2|Genes down-regulated in papillary thyroid carcinoma (PTC) compared to other thyroid tumors.|80","M14300|GOBP_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. [GOC:add]|204","M14330|GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY|C5:GO|Any process that modulates the frequency, rate, or extent of T cell mediated immunity. [GOC:add]|107","M14427|DODD_NASOPHARYNGEAL_CARCINOMA_UP|C2|Genes up-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.|1405","M14463|AACTTT_UNKNOWN|C3:TFT|Genes having at least one occurrence of the highly conserved motif M17 AACTTT in the regions spanning 4 kb centered on their transcription starting sites [-2kb,+2kb].  The motif does not match any known transcription factor binding site.|1928","M14494|GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS|C5:GO|Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus. [GOC:add]|442","M14539|BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP|C2|Genes up-regulated in medullary breast cancer (MBC) relative to ductal breast cancer (DBD).|207","M14544|GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY|C5:GO|Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity. [GOC:add]|263","M14548|GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS|C5:GO|Any process that modulates the frequency, rate or extent of a response to an external stimulus. [GOC:mah]|1175","M14645|GOBP_LEUKOCYTE_CELL_CELL_ADHESION|C5:GO|The attachment of a leukocyte to another cell via adhesion molecules. [GOC:go_curators]|436","M14715|GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell mediated immunity. [GOC:add]|33","M14725|GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION|C5:GO|Any process that activates or increases the rate or extent of cell adhesion to another cell. [GOC:isa_complete]|341","M14774|GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS|C5:GO|Any process that modulates the frequency, rate, or extent of a response to biotic stimulus. [GOC:add]|593","M14818|GOBP_IMMUNE_EFFECTOR_PROCESS|C5:GO|Any process of the immune system that executes a component of an immune response. An effector immune process takes place after its activation. [GO_REF:0000022, GOC:add, ISBN:0781735149]|745","M14878|GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of cell activation. [GOC:ai]|229","M15072|GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell activation. [GOC:ai]|50","M15121|GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY|C5:GO|A toll-like receptor signaling pathway not relying on the MyD88 adaptor molecule. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate an immune response. [GOC:add, ISBN:0781735149, PMID:12467241, PMID:12524386, PMID:12855817, PMID:15585605, PMID:15728447]|16","M15277|GOBP_REGULATION_OF_DEFENSE_RESPONSE|C5:GO|Any process that modulates the frequency, rate or extent of a defense response. [GOC:mah]|907","M15340|GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE|C5:GO|Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species. [GO_REF:0000022, GOC:add, GOC:mtg_sensu, ISBN:0781735149, PMID:15199967, PMID:16177805]|341","M15389|PTF1BETA_Q6|C3:TFT|Genes having at least one occurrence of the motif GRGAAAMBBWCAGS in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the PTF1A [GeneSymbol=PTF1A] transcription factor binding site V$PTF1BETA_Q6 (v7.4 TRANSFAC).|246","M15583|GOMF_SIGNALING_RECEPTOR_BINDING|C5:GO|Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. [GOC:bf, GOC:ceb, ISBN:0198506732]|1540","M15584|GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS|C5:GO|Any process that activates or increases the frequency, rate or extent of T cell death by apoptotic process. [GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|16","M15641|GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. [GOC:ai]|215","M15651|GOBP_T_CELL_MEDIATED_IMMUNITY|C5:GO|Any process involved in the carrying out of an immune response by a T cell. [GO_REF:0000022, GOC:add, ISBN:0781735149]|139","M15747|GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION|C5:GO|Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell activation. [GOC:obol]|37","M15981|RIGGI_EWING_SARCOMA_PROGENITOR_UP|C2|Genes up-regulated in mesenchymal stem cells (MSC) engineered to express EWS-FLI1 [GeneID=2130;2321] fusion protein.|439","M16054|GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION|C5:GO|Any process that stops, prevents, or reduces the rate of production of a cytokine. [GOC:add, ISBN:0781735149]|400","M16084|GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION|C5:GO|Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. [GOC:mah]|43","M16089|GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS|C5:GO|Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune effector process. [GOC:add]|135","M16177|GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS|C5:GO|Any apoptotic process in a lymphocyte, a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin. [CL:0000542, GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|86","M16183|GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION|C5:GO|Any process that modulates the frequency, rate or extent of lymphocyte activation. [GOC:ai]|530","M16192|GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL|C5:GO|Any process that modulates the frequency, rate, or extent of a response to tumor cell. [GOC:add]|30","M16253|GOBP_REGULATION_OF_T_CELL_ACTIVATION|C5:GO|Any process that modulates the frequency, rate or extent of T cell activation. [GOC:ai]|401","M16401|GOBP_T_CELL_APOPTOTIC_PROCESS|C5:GO|Any apoptotic process in a T cell, a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex. [CL:0000084, GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]|61","M16476|KEGG_CELL_ADHESION_MOLECULES_CAMS|C2:CP|Cell adhesion molecules (CAMs)|133","M16514|GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION|C5:GO|Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor superfamily cytokine production. [GO_REF:0000058, GOC:TermGenie, PMID:24187568]|84","M16548|GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS|C5:GO|An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus. [GOC:add, GOC:mtg_sensu, ISBN:0781735149, ISBN:1405196831]|390","M16728|GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN|C5:GO|Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin. [GOC:rl, GOC:sm]|376","M17020|GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION|C5:GO|Any process that activates or increases the rate or extent of T cell proliferation. [GOC:ai]|108","M17126|GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS|C5:GO|Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs. [GOC:ai]|1728","M17311|GOCC_EARLY_ENDOSOME_MEMBRANE|C5:GO|The lipid bilayer surrounding an early endosome. [GOC:pz]|206","M17386|REACTOME_REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY|C2:CP|Regulation of T cell activation by CD28 family|79","M1742|MARSON_BOUND_BY_FOXP3_STIMULATED|C2|Genes with promoters bound by FOXP3 [GeneID=50943] in hybridoma cells stimulated by PMA [PubChem=4792] and ionomycin [PubChem=3733].|1016","M1743|MARSON_BOUND_BY_FOXP3_UNSTIMULATED|C2|Genes with promoters bound by FOXP3 [GeneID=50943] in unstimulated hybridoma cells.|1228","M17514|GOCC_SIDE_OF_MEMBRANE|C5:GO|A cellular component consisting of one leaflet of a membrane bilayer and any proteins embedded or anchored in it or attached to its surface. [GOC:dos]|746","M17582|GOCC_RECYCLING_ENDOSOME_MEMBRANE|C5:GO|The lipid bilayer surrounding a recycling endosome. [GOC:jid, GOC:rph, PMID:10930469, PMID:15601896, PMID:16246101]|109","M17747|GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION|C5:GO|Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion. [GOC:go_curators]|318","M17771|GOCC_RECYCLING_ENDOSOME|C5:GO|An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. [GOC:dph, GOC:jid, GOC:kmv, GOC:rph, PMID:10930469, PMID:15601896, PMID:16246101, PMID:21556374, PMID:21562044]|212","M18699|NFAT_Q6|C3:TFT|Genes having at least one occurrence of the motif NANWGGAAAANN in the regions spanning 4 kb centered on their transcription starting sites [-2kb, +2kb].  This matches the NFAT [GeneSymbol=NFAT], NFATC [GeneSymbol=NFATC] transcription factor binding site V$NFAT_Q6 (v7.4 TRANSFAC).|250","M18810|REACTOME_CO_INHIBITION_BY_PD_1|C2:CP|Co-inhibition by PD-1|28","M18818|GOBP_RESPONSE_TO_BACTERIUM|C5:GO|Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. [GOC:hb]|762"]}]}